P. Stella

发表

Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).

E. Perez, J. Sloan, C. Loprinzi, 2007, International journal of radiation oncology, biology, physics.

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

P. Novotny, J. Sloan, C. Loprinzi, 2002, Pain.

A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.

Seta Shahin, J. Hecht, J. Marshall, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology Settings.

David A. Chambers, B. Kramer, W. McCaskill-Stevens, 2021, JNCI cancer spectrum.

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group ( NCCTG ) trials

E. Perez, A. Dueck, D. Northfelt, 2011 .

Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437

E. Perez, A. Dueck, D. Northfelt, 2011, Clinical Cancer Research.

A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer

Eric B Haura, Roger B Cohen, V. Miller, 2010, Clinical Cancer Research.

Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.

N. Foster, S. Dakhil, A. Jatoi, 2007, The journal of supportive oncology.

“Enjoy glass of wine before eating:” a randomized trial to test the orexigenic effects of this advice in advanced cancer patients

S. Dakhil, R. Qin, A. Jatoi, 2016, Supportive Care in Cancer.

Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.

E. Perez, J. Jett, S. Hillman, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Why do oncologists prescribe--or not prescribe--conventional chemotherapy to geriatric patients with metastatic non-small cell lung cancer?

S. Hillman, K. Rowland, S. Dakhil, 2006, The journal of supportive oncology.

Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group.

N. Foster, S. Dakhil, S. Alberts, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer.

J. Kugler, H. Pitot, P. Burch, 1997, International journal of radiation oncology, biology, physics.

A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC).

M. Socinski, M. Saleh, P. Stella, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Activity of cetuximab in patients with colorectal cancer refractory to both irinotecan and oxaliplatin.

E. Van Cutsem, R. Mayer, H. Lenz, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial.

E. Perez, P. Flynn, T. Fitch, 2012, Clinical breast cancer.

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer

K. Cease, A. Adjei, D. Trump, 2013, Cancer Chemotherapy and Pharmacology.

Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients

J. Jett, J. Sloan, S. Hillman, 2003, Supportive Care in Cancer.

Brief Report: SWOG S1400B (), A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

R. Herbst, K. Kelly, D. Gandara, 2020 .

Brief Report: SWOG S1400B (NCT02785913), A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).

R. Herbst, J. Bradley, K. Kelly, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treated PI 3 K-Positive Patients with Stage IV Squamous Cell Lung Cancer ( Lung-MAP Sub-Study )

Jeffrey, Crawford, R. Herbst, 2019 .

Partnering with payers for success: quality oncology practice initiative, blue cross blue shield of michigan, and the michigan oncology quality consortium.

D. Blayney, T. Ruane, P. Stella, 2009, Journal of oncology practice.

Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

J. Sloan, C. Loprinzi, S. Dakhil, 2013, Journal of the National Cancer Institute.

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

Edward S. Kim, M. Socinski, V. Velcheti, 2022, Nature Medicine.

E4206: AMG 706 and Octreotide in Patients with Low‐Grade Neuroendocrine Tumors

A. Benson, J. Hinshaw, P. Engstrom, 2018, The oncologist.

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial

J. Sloan, C. Loprinzi, K. Rowland, 2011, Supportive Care in Cancer.

N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.

E. Perez, D. Northfelt, S. Gamini, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology Group.

S. Adak, C. Belani, S. Aisner, 2004, Clinical lung cancer.

N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.

E. Perez, D. Northfelt, S. Gamini, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

N0436: A phase II trial of irinotecan plus cetuximab in patients with metastatic breast cancer and prior anthracycline and/or taxane-containing therapy

E. Perez, M. Goetz, T. Hobday, 2008 .

Abstract S3-06: A phase III trial evaluating pCR in patients with HR+, HER2-positive breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab (TCHP) +/- estrogen deprivation: NRG Oncology/NSABP B-52

S. Paik, N. Wolmark, S. Swain, 2017 .

Abstract S1-02: PrECOG 0102: A randomized, double-blind, phase II trial of fulvestrant plus everolimus or placebo in post-menopausal women with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) resistant to aromatase inhibitor (AI) therapy

J. Manola, B. Ramaswamy, A. Wolff, 2017 .

Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.

R. Hurt, P. Novotny, J. Sloan, 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study

T. Julian, C. Geyer, N. Wolmark, 2014, Breast Cancer Research and Treatment.

Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia.

P. Novotny, J. Sloan, C. Loprinzi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

279 Correlation of acne rash and tumor response with cetuximab monotherapy in patients with colorectal cancer refractory to both irinotecan and oxaliplatin

R. Mayer, H. Lenz, E. Cutsem, 2004 .

Cost comparison of XELOX compared to FOLFOX4 with or without bevacizumab (bev) in metastatic colorectal cancer

L. Saltz, J. Cassidy, J. Fuloria, 2007 .

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

D. Sargent, R. Goldberg, K. Rowland, 2002, International journal of gastrointestinal cancer.

N0337: Phase II study of capecitabine in combination with vinorelbine and trastuzumab for the first or second treatment of HER2+ metastatic breast cancer.

E. Perez, J. Kugler, P. Flynn, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of paclitaxel plus carboplatin as first‐line chemotherapy for women with metastatic breast carcinoma

E. Perez, L. Hartmann, J. Ingle, 2000, Cancer.

Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials.

D. Sargent, N. Foster, S. Dakhil, 2010, International journal of oncology.

Abstract P3-12-01: Impact of treatment on quality of life (QOL) and menstrual history (MH) in the NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide

E. Perez, N. Wolmark, P. Ward, 2015 .

A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.

R. Natale, D. Stewart, P. Stella, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA.

J. Sloan, D. Moore, C. Loprinzi, 2011, The journal of supportive oncology.

A Phase III Randomized, Double Blind, Placebo-Controlled Study of Pilocarpine for Vaginal Dryness: NCCTG study N04CA 1

J. Sloan, C. Loprinzi, R. Zon, 2011 .

Weekly Carboplatin and Paclitaxel in Elderly Non–Small-Cell Lung Cancer Patients (≥65 Years of Age): A Phase II North Central Cancer Treatment Group Study

E. Perez, J. Jett, S. Hillman, 2003, American journal of clinical oncology.

A Phase II Study of Topical Ceramides for Cutaneous Breast Cancer

J. Sloan, C. Loprinzi, S. Alberts, 2003, Breast Cancer Research and Treatment.

NCCTG N0572 phase I/II trial of sorafenib and temsirolimus in patients with recurrent glioblastoma: A North Central Cancer Treatment Group study.

J. Sarkaria, B. Scheithauer, J. Buckner, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

J. Jett, S. Hillman, K. Rowland, 2006, Cancer investigation.

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

D. Szydlo, C. Loprinzi, J. Krook, 2010, The journal of supportive oncology.

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

J. Nemunaitis, H. Hurwitz, Z. Wainberg, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.

P. Novotny, J. Sloan, C. Loprinzi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States

R. Hurt, P. Novotny, J. Sloan, 2009, Journal of public health.

SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study).

R. Herbst, K. Kelly, D. Gandara, 2020, Clinical lung cancer.

Clinical Challenges and Opportunities With Current Electronic Health Records: Practicing Oncologists' Perspective.

L. Bosserman, D. Patt, P. Stella, 2018, Journal of oncology practice.

Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.

B. Feinberg, T. Ruane, S. Milligan, 2012, Journal of oncology practice.

Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]).

P. Novotny, C. Loprinzi, RobertI Miller, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.

D. Moore, N. Foster, S. Alberts, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.

E. Van Cutsem, H. Lenz, Z. Tsuchihashi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second- or third-line treatment of patients with EGFR wild-type advanced non-small cell lung cancer (ECOG-ACRIN 1512): a phase 2 randomised controlled trial

J. Neal, H. Wakelee, D. Carbone, 2016, The Lancet. Oncology.

A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group Study N0528

S. Mandrekar, A. Adjei, A. Adjei, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

M. Mehta, P. Wen, H. Shih, 2018, Neuro-oncology.

Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222

S. Hillman, K. Rowland, A. Jatoi, 2011, Cancer investigation.

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

D. Richel, T. Ciuleanu, S. Cascinu, 2017, BMC Cancer.

Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery

K. Owzar, L. Minasian, J. Moul, 2008, Cancer Epidemiology Biomarkers & Prevention.

Vandetanib Plus Chemotherapy for Induction Followed by Vandetanib or Placebo As Maintenance for Patients with Advanced Non–Small-Cell Lung Cancer: A Randomized Phase 2 PrECOG Study (PrE0501)

J. Manola, S. Dakhil, J. Schiller, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621.

R. Marks, N. Foster, A. Adjei, 2014, Lung cancer.

Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients

S. Ansell, C. Erlichman, S. Geyer, 2006, Clinical Cancer Research.

Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Edward S. Kim, R. Schilsky, E. Voest, 2018, JCO precision oncology.

Phase III double-blinded, randomized trial to evaluate the use of black cohosh in the treatment of hot flashes: A North Central Cancer Treatment Group study

P. Novotny, J. Sloan, C. Loprinzi, 2005 .

A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)

G. Bepler, D. Gandara, J. Moon, 2014, Cancer.

Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer

E. Perez, C. Geyer, P. Ward, 2022, Breast Cancer Research and Treatment.

Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial.

N. Wolmark, R. Valicenti, G. Yothers, 2021, JAMA oncology.

Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)

A. Grothey, S. Dakhil, S. Alberts, 2020, Therapeutic advances in medical oncology.

Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.

S. Mandrekar, D. Gandara, A. Adjei, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222

S. Hillman, K. Rowland, A. Jatoi, 2009, Cancer management and research.

A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422).

N. Foster, A. Adjei, K. Rowland, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of cetuximab and radiation in elderly and / or poor performance status patients with locally advanced non-small-cell lung cancer ( N 0422 )

N. Foster, A. Adjei, K. Rowland, 2010 .

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer

E. Heath, P. Mack, A. Hussain, 2019, The oncologist.

Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.

R. Hurt, P. Novotny, J. Sloan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nicotine P atch T herapy B ased o n S moking R ate F ollowed b y Bupropion f or P revention o f R elapse t o S moking

R. Hurt, P. Novotny, J. Sloan, 2003 .

The prevalence of weight concerns in a smoking abstinence clinical trial.

M. Clark, C. Patten, R. Hurt, 2006, Addictive behaviors.

Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance).

J. Sloan, C. Loprinzi, L. Shuster, 2014 .

Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderly

J. Jett, S. Mandrekar, J. Krook, 2005, Cancer.

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.

J. Jett, S. Geyer, S. Schild, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled Analysis.

N. Foster, A. Adjei, K. Olivier, 2012 .

Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer.

J. Jett, R. Marks, J. Kugler, 2002, International journal of radiation oncology, biology, physics.

Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen.

S. Torp-Pedersen, P. Littrup, F Lee, 1989, Radiology.

C. Friese, K. Mendelsohn-Victor, P. Stella, 2016, Journal of oncology practice.

Predictive Biomarkers and Personalized Medicine Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials , N 0234 / 336 / 436 / 437

E. Perez, A. Dueck, D. Northfelt, 2011 .

The O utcome o f C ombined-Modalit y T herapy f or S tage I II Non-Small-Cell L ung C ancer i n t he E lderly

J. Jett, S. Geyer, S. Schild, 2003 .

A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials

J. Buckner, J. Sloan, P. Novotny, 2008 .

Mortality associated with daily bolus 5‐fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin

D. Sargent, R. Goldberg, R. Morton, 2004, Cancer.

Impact of diabetes and insulin use on prognosis in patients with resected pancreatic cancer: an ancillary analysis of NRG Oncology RTOG 9704.

R. Abrams, A. Benson, C. Fuchs, 2020, International journal of radiation oncology, biology, physics.

Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study

N. Wolmark, K. Pogue-Geile, Rim S. Kim, 2020, Clinical Cancer Research.

A phase II second-line study of pemetrexed (pem) in combination with bevacizumab (bev) in patients with advanced non-small cell lung cancer (NSCLC): An NCCTG and SWOG study

S. Mandrekar, D. Gandara, A. Adjei, 2008 .

Primary efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC).

M. Socinski, V. Velcheti, D. Fabrizio, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results.

Edward S. Kim, M. Socinski, V. Velcheti, 2018 .

Tolerability of lapatinib given concurrently with paclitaxel and trastuzumab as part of adjuvant therapy in patients with resected HER2+ breast cancer: initial safety data from the Mayo Clinic cancer research consortium trial RC0639.

E. Perez, S. Franco, S. Dakhil, 2009 .

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

D. Richel, D. V. Von Hoff, T. Ciuleanu, 2017, BMC Cancer.

Elderly patients with metastatic esophageal/gastric cancer: A pooled analysis of age-based outcomes from 8 consecutive North Central Cancer Treatment Group (NCCTG) therapeutic trials

D. Sargent, N. Foster, S. Dakhil, 2008 .

A phase III trial evaluating three doses of citalopram for hot flashes: NCCTG trial N05C9

J. Sloan, C. Loprinzi, S. Dakhil, 2008 .

A randomized double-blind phase 2 study of ruxolitinib (RUX) or placebo (PBO) with capecitabine (CAPE) as second-line therapy in patients (pts) with metastatic pancreatic cancer (mPC).

Nikhil Uppal, Jason Clark, Philip J. Stella, 2014 .

Anti-Tumor Activity of Single-Agent CCI-779 for Relapsed Mantle Cell Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group.

R. Fonseca, K. Rowland, S. Dakhil, 2004 .

O-0032PHASE III RANDOMIZED, PLACEBO(PL)-CONTROLLED, DOUBLE-BLIND STUDY OF INTRAVENOUS CALCIUM/MAGNESIUM (CAMG) TO PREVENT OXALIPLATIN-INDUCED SENSORY NEUROTOXICITY (SNT), N08CB: AN ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY STUDY1

C. Loprinzi, A. Grothey, S. Dakhil, 2013 .

Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An alliance for clinical trials in oncology study.

C. Loprinzi, A. Grothey, S. Dakhil, 2013 .

The Results of combined modality therapy for limited stage small cell lung cancer (LD-SCLC) in the elderly.

J. Jett, S. Mandrekar, A. Adjei, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypomagnesemia in patients with stage IV colorectal cancer treated with cetuximab as a single agent

P. Stella, E. Carson, A. Novak, 2005 .

Phase II trial combining nab-paclitaxel (NP), gemcitabine (G), and bevacizumab (B) in patients (pts) with metastatic breast cancer (MBC): NCCTG N0735.

E. Perez, A. Dueck, D. Northfelt, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation On the Erythropoietic Response to Darbepoetin Alfa for Patients with Chemotherapy-Associated Anemia: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC).

P. Novotny, J. Sloan, C. Loprinzi, 2009 .

Bortezomib, Paclitaxel, and Carboplatin as a First-Line Regimen for Patients with Metastatic Esophageal, Gastric, and Gastroesophageal Cancer: Phase II Results from the North Central Cancer Treatment Group (N044B)

D. Moore, N. Foster, K. Rowland, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States

P. Novotny, J. Sloan, C. Loprinzi, 2009, Journal of Public Health.

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.

P. Novotny, J. Sloan, C. Loprinzi, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222

S. Hillman, K. Rowland, A. Jatoi, 2009 .

CMR-4547-Is social support associated with improved clinical

S. Hillman, K. Rowland, A. Jatoi, 2009 .

Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.

P. Novotny, J. Sloan, C. Loprinzi, 1999, The New England journal of medicine.

Randomized phase II trial of docetaxel (Doc) and prednisone (Pred) with or without AZD2171 (cediranib), in chemotherapy-naive, metastatic castrate-resistant prostate cancer (mCRPC) (NCI 7451).

A. Hussain, U. Vaishampayan, T. Flaig, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.